NewsRoom

Chime Biologics Received Commercial Manufacturing License Indicating the Kick-off into the Era of Commercial Production

Chime BIologics Announces a Strategic Collaboration with MABGEEK to Accelerate the Development of Monoclonal Antibody MG-K10

Chime Biologics Successfully Passed the Pre-Approval Inspection (PAI) Conducted by the NMPA, Realizing a Leap to Commercial Manufacturing

categoryidArraymk-test